NCT01170559

Brief Summary

Heart rhythm abnormalities underlie one of the common presenting complaints to the A\&E and out-patient departments, specifically awareness of heart beats or palpitations. Unless an ECG (electrocardiogram) tracing of the heart rhythm can be recorded while the patient is having symptoms, it is very difficult to determine the cause of the palpitations. The conventional approach is to refer these patients from the emergency departments to the Cardiology outpatients where they undergo repeated short term rhythm monitoring hoping to record the rhythm underlying the patient's complaint. Unfortunately, this often yields no results thus delaying definitive treatment and incurring extra costs of repeated investigations and A\&E presentations. This study aims to compare the ability of the conventional approach to establish a definite diagnosis compared to that of an early invasive monitoring approach with a small implantable device that records the heart rhythm at all time for up to 18 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 27, 2010

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

January 5, 2023

Status Verified

August 1, 2014

Enrollment Period

6.3 years

First QC Date

July 26, 2010

Last Update Submit

January 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint of the study is the proportion of patients achieving a definite diagnosis in each of the two groups at the end of one year

    1 year

Secondary Outcomes (2)

  • The time taken from randomisation in the A&E to making the diagnosis (if any) in each group

    1 Year

  • The cost of achieving a diagnosis in each group

    1 Year

Study Arms (2)

Group 1: ILR Group

EXPERIMENTAL

Group allocated to receiving an ILR in the A\&E department.

Device: Implantable Loop Recorder

Group 2: Conventional

NO INTERVENTION

Group randomised to conventional lines of investigation

Interventions

Also known as: Reveal XT
Group 1: ILR Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Good history of episodic symptomatic sustained palpitations (sudden onset and offset, fast heart beats, may be associated with shortness of breath or dizziness)
  • Terminates before presentation to hospital
  • Episodes occur at a frequency of less than once every two weeks
  • Never previously caught on ECG or ambulatory monitoring
  • Normal resting ECG

You may not qualify if:

  • Contraindication to ILR implantation i.e. ongoing oral anticoagulation with INR \>1.6, ongoing infection, sepsis or fever, etc.
  • Palpitations suggestive of extrasystoles (single missed or dropped beats)
  • Known or suspected severe valvular or myocardial heart disease
  • An audible heart murmur
  • Any abnormality on the surface ECG
  • Thyrotoxicosis
  • Patients who refuse an ILR when offered will not be included in either limb of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barts and the London NHS Trust

London, EC1A 7BE, United Kingdom

Location

Study Officials

  • Richard Schilling, MD, FRCP

    Barts and the London NHS Trust, Queen Mary University of London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2010

First Posted

July 27, 2010

Study Start

April 1, 2010

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

January 5, 2023

Record last verified: 2014-08

Locations